# ESSENCE is a Quality Improvement Study That Evaluates the Impact of Ada's AI-powered Core Symptom Assessment Technology on Clinical Workflow and Individual Healthcare Guidance, Following the November 2021 Integration of the Tool Into the CUF Hospital Network. Study Duration Nov 2024-Oct 2025

> **NCT06846957** · — · COMPLETED · sponsor: **Ada Health GmbH** · enrollment: 1470 (actual)

## Conditions studied

- Symptom Assessment

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06846957
- **Lead sponsor:** Ada Health GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-08
- **Primary completion:** 2024-10-31
- **Final completion:** 2024-10-31
- **Target enrollment:** 1470 (ACTUAL)
- **Last updated:** 2025-02-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06846957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06846957, "ESSENCE is a Quality Improvement Study That Evaluates the Impact of Ada's AI-powered Core Symptom Assessment Technology on Clinical Workflow and Individual Healthcare Guidance, Following the November 2021 Integration of the Tool Into the CUF Hospital Network. Study Duration Nov 2024-Oct 2025". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06846957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*